✦ LIBER ✦

Effects of the Luteinizing Hormone-Releasing Hormone Agonist Leuprolide on Lipoproteins, Fibrinogen and Plasminogen Activator Inhibitor in Patients with Benign Prostatic Hyperplasia

✍ Scribed by Eri, Lars M.; Urdal, Petter; Bechensteen, Anne G.

Book ID: 122957057
Publisher: Lippincott Williams and Wilkins
Year: 1995
Tongue: English
Weight: 522 KB
Volume: 154
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(01)67239-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE GONADOTROPIN-RELEASING HORMONE ANTAG

THE GONADOTROPIN-RELEASING HORMONE ANTAGONIST ABARELIX DEPOT VERSUS LUTEINIZING HORMONE RELEASING HORMONE AGONISTS LEUPROLIDE OR GOSERELIN: INITIAL RESULTS OF ENDOCRINOLOGICAL AND BIOCHEMICAL EFFICACIES IN PATIENTS WITH PROSTATE CANCER

✍ TOMERA, KEVIN; GLEASON, DONALD; GITTELMAN, MARC; MOSELEY, WILLIAM; ZINNER, NORMA 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 76 KB

Long-term effects of a short course of n

Long-term effects of a short course of neoadjuvant luteinizing hormone-releasing hormone analogue and radical radiotherapy on the hormonal profile in patients with localized prostate cancer

✍ Vedang Murthy; Andrew R. Norman; Yolanda Barbachano; Christopher C. Parker; Davi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Effect of 2-week combination therapy wit

Effect of 2-week combination therapy with the luteinizing hormone-releasing hormone (LHRH) agonist [d-Trp6, des-Gly-NH210]LHRH ethylamide and the antiandrogen flutamide on prostate structure and steroid levels in the dog

✍ Lacoste, Daniel; Dubé, Donald; Bélanger, Alain; Labrie, Fernand 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 908 KB